Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds

Friday, March 6, 2026 · mangoceuticals, inc.

AI Briefing

Mangoceuticals, Inc. files PCT patent application for MGX-0024 antiviral technology to combat animal and bird virus infections.
The technology is a key component of the company's innovative wellness solutions under the brands MangoRx and PeachesRx.
The filing secures broad global patent protection for the antiviral animal feed and drinking water additive technology.